SERUM CALCIUM, PHOSPHORUS, MAGNESIUM AND ALBUMIN LEVELS IN PATIENTS WITH CHRONIC RENAL FAILURE IN SENNAR HOSPITAL FOR RENAL DISEASES, SENNAR STATE, SUDAN, AUGUST 2018

Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 9

Abstract

Background: Chronic kidney disease (CKD) is an irreversible loss of renal function for at least three months. It is accompanied by profound changes in calcium, phosphorus, magnesium and albumin metabolism. These alterations contribute to serious complications such as cardiovascular disease and bone disease. Objective: This study aim to evaluate serum calcium, phosphorus, magnesium and albumin levels in patients with chronic renal failure. Materials and Methods: The study includes 120 samples, 80 blood samples were taken from patients with chronic renal failure in Sennar hospital for renal diseases included 44 males (55%) and 36 females (45%), the average age of the patients was 44.26 ± 19.10 years, and 40 apparently healthy individuals (control group) included 18 males (45%) and 22 females (55%) the average age of control group was 37.1 ± 18.3 years. Calcium, phosphorus, magnesium and albumin levels were measured by using chemistry analyzer A15. Statistical tests were used to assess difference in the mean of studied concentrations between cases and the control group. Result: The results showed that calcium and albumin concentrations were significantly lower in the patients (M±SD = 8.63 ± 1.37, M±SD = 3.39 ± 0.82) compared with controls (M±SD = 9.13 ± 0.463, M±SD = 3.8 ± 0.41, P = 0.000, P = 0.001). Phosphorus and magnesium concentrations were significantly higher in the patients (M±SD = 3.9 ± 2.07, M±SD = 2.69 ± 0.85) compared with control group (M±SD = 3.13 ± 0.40, M±SD = 1.93 ± 0.27, P = 0.000, P = 0.000), respectively. Conclusion: In this study hypocalcaemia was reported in 46% of the patients, hyperphosphatemia was found in 29% of the patients, and hypermagnesemia and hypoalbuminemia were found in more than half of the patients (66%, 61%, respectively). More studies must be done to confirm these results and screening programs should be done to reduce the burden and to prevent the complications of chronic kidney disease.

Authors and Affiliations

Dr. Yasir Hakim

Keywords

Related Articles

PREPARATION AND IDENTIFICATION OF COMPLEXES IONS CO(II), CU(II) LIGAND 2- (BENZOTHIOZOLYL AZO-4- BENZYL PHENOL

In this paper, chelate compounds of Co(II) and Cu(II) as a result of making reactions for those ions with the ligand 2-(Benzothiozolyl azo- 4- benzyl phenol has been presented. The preparing procedure for compounds has b...

RETURN TO NATURE FOR EFFICACIOUS AND SAFER MEDICINAL PROSPECTS: A REVIEW

Traditional medicine also known as indigenous or folk medicine comprises medical knowledge systems that developed over generations within various societies before the era of modern medicine. We have gone through literatu...

THE EFFICACY OF DEXAMETHASONE AND PROPOFOL IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING AFTER LAPAROSCOPIC CHOLECYSTECTOMY

Background: Postoperative nausea and vomiting (PONV) are one of the most common complaints following anesthesia and surgery. This study was designed to evaluate the efficacy of dexamethasone, propofol to prevent PONV in...

EFFECTS OF ARTIFICIAL SWEETENER(ASPARTAME) ON THE WEIGHT OF IMMUNE ORGANS AND GRANULOCYTES CELLS IN RATS

This study aimed to determine the effect of aspartame on the white blood cells. Used for this study 24 adult male rats and 24 adult female rats, with age of 65-70 day, almost on an average live weight between (185-200) g...

BRIEF REVIEW OF GANDHAKA WITH IT'S KUSTHAGHNA PROPERTY

Gandhaka (sulphur) is the first mineral drug in ‘Uparasa group’.[1] It is a multi-valent non-metal which is abundant. In its native form, sulpher is a yellow crystalline solid, which is odourless and tasteless.In Rasasha...

Download PDF file
  • EP ID EP627015
  • DOI -
  • Views 88
  • Downloads 0

How To Cite

Dr. Yasir Hakim (2018). SERUM CALCIUM, PHOSPHORUS, MAGNESIUM AND ALBUMIN LEVELS IN PATIENTS WITH CHRONIC RENAL FAILURE IN SENNAR HOSPITAL FOR RENAL DISEASES, SENNAR STATE, SUDAN, AUGUST 2018. World Journal of Pharmaceutical Research, 7(9), 62-82. https://europub.co.uk/articles/-A-627015